Fraxin launches VMA Fat Loss

04 Dec 2019

Manufacturing company Fraxin has added a second product to its portfolio, Fraxin VMA Fat Loss.

The treatment aims to reduce subcutaneous adipose tissue and is suitable for use in the chin, breast, stomach, hips, buttocks, back, arms and thighs, according to the company. Comprising red-purple sea algae extracts, the product is administered via derma pen, derma roller, derma stamp, microneedle and microchannel.

A representative of the manufacturing team at Fraxin LLC stated, “Fraxin VMA is designed to deliver equal or better results than the currently available deoxycholate products on the market, all without the requirement for painful injections, and at a fraction of the cost.” 


Log-in to post a comment